The Lancet: July 18, 2013
The Lancet in conversation with
English - July 18, 2013 07:00 - 6 minutes - 4.8 MBLife Sciences Science Education medicine research covid diseases science health care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Lancet: July 12, 2013
Next Episode: The Lancet: July 22, 2013
Richard Gelber discusses results of the HERA trial comparing 2 years vs 1 year trastuzumab for HER2 positive breast cancer.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv